{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:34:19Z","timestamp":1789450459715,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:00:00Z","timestamp":1592524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-108686"],"award-info":[{"award-number":["R01-108686"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG044342"],"award-info":[{"award-number":["R01-AG044342"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AG05882"],"award-info":[{"award-number":["R01-AG05882"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS086074"],"award-info":[{"award-number":["R01-NS086074"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-NS092093"],"award-info":[{"award-number":["R01-NS092093"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56-NS113549"],"award-info":[{"award-number":["R56-NS113549"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012513","name":"Coins for Alzheimer's Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00563","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:49:08Z","timestamp":1592527748000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Ablating Tau Reduces Hyperexcitability and Moderates Electroencephalographic Slowing in Transgenic Mice Expressing A53T Human \u03b1-Synuclein"],"prefix":"10.3389","volume":"11","author":[{"given":"Samuel T.","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyssa","family":"Fahrenkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Choquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Vermilyea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Vossel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/jad-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia","volume":"60","author":"Beagle","year":"2017","journal-title":"J Alzheimers Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3389\/fneur.2019.01266","article-title":"A longitudinal study of epileptic seizures in Alzheimer's disease","volume":"10","author":"Baker","year":"2019","journal-title":"Front Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer's disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/mds.870130327","article-title":"Cortical myoclonus in levodopa-responsive parkinsonism","volume":"13","author":"Caviness","year":"1998","journal-title":"Mov Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ana.67","article-title":"Clinical and pathological features of a parkinsonian syndrome in a family with an Ala53Thr \u03b1-synuclein mutation","volume":"49","author":"Spira","year":"2001","journal-title":"Ann Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/1531-8257(200001)15:1<140::aid-mds1022>3.0.co;2-5","article-title":"Electrophysiological observations in hereditary parkinsonism-dementia with Lewy body pathology","volume":"15","author":"Caviness","year":"2000","journal-title":"Mov Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"20119","DOI":"10.1038\/srep20119","article-title":"Interictal spikes during sleep are an early defect in the Tg2576 mouse model of beta-amyloid neuropathology","volume":"6","author":"Kam","year":"2016","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2017.09.026","article-title":"Seizure susceptibility in the APP\/PS1 mouse model of Alzheimer's disease and relationship with amyloid beta plaques","volume":"1677","author":"Reyes-Marin","year":"2017","journal-title":"Brain Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/acn3.257","article-title":"Network dysfunction in alpha-synuclein transgenic mice and human Lewy body dementia","volume":"2","author":"Morris","year":"2015","journal-title":"Ann Clin Transl Neurol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/s1474-4422(03)00619-7","article-title":"Dementia with Lewy bodies","volume":"3","author":"McKeith","year":"2004","journal-title":"Lancet Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology."},{"key":"B14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1136\/jnnp.66.3.401","article-title":"EEG findings in dementia with Lewy bodies and Alzheimer's disease","volume":"66","author":"Briel","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1073\/pnas.1217144110","article-title":"Striatal GABAergic and cortical glutamatergic neurons mediate contrasting effects of cannabinoids on cortical network synchrony","volume":"110","author":"Sales-Carbonell","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B16","doi-asserted-by":"publisher","first-page":"7111","DOI":"10.1523\/jneurosci.0347-11.2011","article-title":"Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice","volume":"31","author":"Brooks","year":"2011","journal-title":"J Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"11915","DOI":"10.1523\/jneurosci.3821-06.2006","article-title":"Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis","volume":"26","author":"Larsen","year":"2006","journal-title":"J Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/s0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science."},{"key":"B20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/mds.25421","article-title":"Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease","volume":"28","author":"Appel-Cresswell","year":"2013","journal-title":"Mov Disord."},{"key":"B21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding \u03b1-synuclein in Parkinson's disease","volume":"18","author":"Kr\u00fcger","year":"1998","journal-title":"Nat Genet."},{"key":"B23","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.21380","article-title":"Genomic investigation of alpha-synuclein multiplication and parkinsonism","volume":"63","author":"Ross","year":"2008","journal-title":"Ann Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00401-002-0563-3","article-title":"Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred","volume":"104","author":"Duda","year":"2002","journal-title":"Acta Neuropathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1523\/jneurosci.0344-18.2018","article-title":"A53T mutant alpha-synuclein induces tau-dependent postsynaptic impairment independently of neurodegenerative changes","volume":"38","author":"Teravskis","year":"2018","journal-title":"J Neurosci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 \u2013> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00401-019-02032-w","article-title":"Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of alpha-synucleinopathy","volume":"138","author":"Singh","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/syn.890140102","article-title":"Expression of c-fos protein in the experimental epilepsy induced by pilocarpine","volume":"14","author":"Barone","year":"1993","journal-title":"Synapse."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1523\/jneurosci.20-05-01831.2000","article-title":"Surviving granule cells of the sclerotic human hippocampus have reduced Ca(2+) influx because of a loss of calbindin-D(28k) in temporal lobe epilepsy","volume":"20","author":"N\u00e4gerl","year":"2000","journal-title":"J Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","article-title":"Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease","volume":"55","author":"Palop","year":"2007","journal-title":"Neuron."},{"key":"B31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/82868","article-title":"Neurotrophins are required for nerve growth during development","volume":"4","author":"Tucker","year":"2001","journal-title":"Nat Neurosci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1093\/sleep\/25.6.677","article-title":"Telemetric recording of sleep and home cage activity in mice","volume":"25","author":"Tang","year":"2002","journal-title":"Sleep."},{"key":"B33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2004.02.003","article-title":"Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation","volume":"19","author":"Morrow","year":"2005","journal-title":"Brain Behav Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3233\/jpd-140374","article-title":"Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein","volume":"4","author":"McDowell","year":"2014","journal-title":"J Parkinsons Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer's disease: causes and clinical relevance","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/brain\/awm322","article-title":"EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up","volume":"131","author":"Bonanni","year":"2008","journal-title":"Brain."},{"key":"B37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","article-title":"Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model","volume":"316","author":"Roberson","year":"2007","journal-title":"Science."},{"key":"B38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/jneurosci.4152-10.2011","article-title":"Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease","volume":"31","author":"Roberson","year":"2011","journal-title":"J Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/ejn.12507","article-title":"Tau phosphorylation and tau mislocalization mediate soluble Abeta oligomer-induced AMPA glutamate receptor signaling deficits","volume":"39","author":"Miller","year":"2014","journal-title":"Eur J Neurosci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e17953","DOI":"10.1371\/journal.pone.0017953","article-title":"Tauopathic changes in the striatum of A53T alpha-synuclein mutant mouse model of Parkinson's disease","volume":"6","author":"Wills","year":"2011","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/cdd.2014.179","article-title":"GSK-3\u03b2 dysregulation contributes to Parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and \u03b1-synuclein","volume":"22","author":"Credle","year":"2015","journal-title":"Cell Death Differen."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1111\/j.1460-9568.2007.05601.x","article-title":"Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease","volume":"25","author":"Babiloni","year":"2007","journal-title":"Eur J Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neurobiolaging.2008.03.025","article-title":"Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years","volume":"31","author":"Stomrud","year":"2010","journal-title":"Neurobiol Aging."},{"key":"B46","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1212\/WNL.64.12_suppl_3.S12","article-title":"Sleep issues in Parkinson's disease","volume":"64","author":"Adler","year":"2005","journal-title":"Neurology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3233\/jpd-120130","article-title":"Neuronal expression of familial Parkinson's disease A53T alpha-synuclein causes early motor impairment, reduced anxiety and potential sleep disturbances in mice","volume":"3","author":"Rothman","year":"2013","journal-title":"J Parkinsons Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12017-012-8181-2","article-title":"Sleep disturbances in Alzheimer and Parkinson's diseases","volume":"14","author":"Rothman","year":"2012","journal-title":"Neuromol Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1002\/jnr.22331","article-title":"Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior","volume":"88","author":"Graham","year":"2010","journal-title":"J Neurosci Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","article-title":"Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice","volume":"21","author":"Unger","year":"2006","journal-title":"Neurobiol Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","article-title":"Hyperactivity and impaired response habituation in hyperdopaminergic mice","volume":"98","author":"Zhuang","year":"2001","journal-title":"Proc Natl Acad Sci USA."},{"key":"B52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/epi.13389","article-title":"EEG desynchronization during phasic REM sleep suppresses interictal epileptic activity in humans","volume":"57","author":"Frauscher","year":"2016","journal-title":"Epilepsia."},{"key":"B53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/jsr.12533","article-title":"Suppression of interictal spikes during phasic rapid eye movement sleep: a quantitative stereo-electroencephalography study","volume":"26","author":"Campana","year":"2017","journal-title":"J Sleep Res."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00563\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T00:49:11Z","timestamp":1592527751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00563\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":53,"alternative-id":["10.3389\/fneur.2020.00563"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00563","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"article-number":"563"}}